First, the direct answer. Burnout has become the entry ticket of psychedelic marketing in Europe: platforms and retreats now sell ketamine programmes and "psychedelic-assisted therapy" for burnout by name. Here is what the evidence actually supports in 2026: nothing pharmacological is approved for burnout anywhere in Europe, and neither ketamine nor any psychedelic has solid trial evidence as a burnout treatment. That is not a technicality. Burnout, as the WHO classifies it, is an occupational phenomenon (the result of chronic workplace stress that has not been successfully managed), and what helps starts with the work, the recovery and the correct diagnosis, not with a substance. This page walks through what burnout is, what genuinely helps, when it is really depression wearing a work costume, and exactly which questions to put, in writing, to anyone selling you a burnout programme.
TL;DR Burnout per ICD-11 is an occupational phenomenon (exhaustion, mental distance from work, reduced efficacy), not a disease, and no medicine is approved for it. What has evidence: changing the work situation, real recovery, structured psychological support, and treating the depression or anxiety disorder that "burnout" often turns out to be. Ketamine and psychedelics: no approval, no solid burnout trials; offers using that framing are ahead of the science, and a serious clinic will name the actual diagnosis it treats. If your exhaustion comes with persistent low mood, loss of interest and the rest of the depressive picture, the depression ladder is the mapped route, including defined options when standard treatment has failed.
What burnout is: and why the definition matters
In the WHO's ICD-11, burn-out is defined as an occupational phenomenon: a syndrome resulting from chronic workplace stress that has not been successfully managed, with three dimensions, exhaustion, increased mental distance from or cynicism about one's job, and reduced professional efficacy. It is explicitly not classified as a medical condition. That sounds like semantics; it is the opposite. If burnout is a stress phenomenon anchored in the work situation, then treatments aimed at your brain chemistry are aiming at the wrong layer, and any programme that never discusses your working conditions is treating the word, not the problem.
The definition also explains why no drug is approved for burnout: regulators approve medicines for diseases with defined diagnostic criteria and trial endpoints. Burnout has neither in the pharmaceutical sense, which is precisely why it is so useful as a marketing term. It is common, it is real suffering, it carries less stigma than "depression", and no evidence standard constrains what can be promised against it.
What actually helps
The unglamorous list, in rough order of evidence and logic. The work situation itself: workload, control, recognition, conflict, the drivers named in the research literature. Interventions that change the situation (negotiated workload, role change, structured return-to-work plans, and yes, sometimes leaving) address the cause rather than the symptom; occupational-health services and works doctors exist for exactly this conversation. Recovery that deserves the name: sleep restored over weeks, real time off, and the finding that recovery fails when the stressor resumes unchanged, which loops back to the first point. Structured psychological support: CBT-based and stress-management approaches have the best of the (modest) intervention evidence, help most when combined with work-directed change, and give you tools that outlast the episode. Treating what is actually there: the sleep disorder, the alcohol use that crept up, the anxiety disorder, and above all the depression, which brings us to the question that matters most.
The question that matters most: is it depression?
Exhaustion, emotional flatness, cognitive fog, withdrawal: the overlap between severe burnout and a depressive episode is large, and misdiagnosis runs in both directions. The practical difference is enormous: depression is a medical condition with a mapped treatment ladder; psychotherapy, medication with defined adequate trials, and, where two treatments have genuinely failed, the treatment-resistant pathway that includes options like esketamine with published criteria. If your "burnout" includes persistent low mood most of the day, loss of interest in things outside work, guilt or worthlessness, or any thought of self-harm, that is a picture for a clinician, not for a workplace intervention, and our depression options guide maps every next step, honestly, including the ones that involve this site's directory. A structured screen with your GP or a psychiatrist is one appointment; it changes everything downstream. (If you are in crisis, contact your local emergency or crisis service now.)
Where ketamine and psychedelics really stand for burnout
The claim to test is specific, so test it specifically. Ketamine's evidence is in depression, reviewed honestly in our ketamine evidence guide, and esketamine's European approval is for treatment-resistant depression. There are no robust trials of ketamine for burnout, and burnout appears in no approval and no treatment guideline as a ketamine indication. Psilocybin's evidence is likewise in depression and end-of-life distress; there is no European approval for any indication and no burnout trial behind the retreat marketing. So when a programme advertises ketamine or psychedelics for burnout by name, one of two things is happening: either they have diagnosed something else, usually depression, and are using the softer word to sell it, or they are treating an occupational stress phenomenon with a dissociative anaesthetic on no evidence. The first is a transparency problem; the second is an evidence problem. Neither is disqualifying a priori (off-label depression treatment at a careful clinic is legal and sometimes right), but you deserve to know which one you are buying.
Three questions, in writing, before any money moves: What diagnosis, exactly, will you record and treat; burnout is not one, so what is? What published evidence supports this treatment for that diagnosis? And what happens after the programme, who follows me up, and what is the plan if nothing changes? A serious provider answers all three without friction; the choosing-a-clinic guide covers the rest of the checklist, and every provider in our directory carries its verification sources on the record.
Frequently asked questions
Is there any approved medication for burnout?
No, not in Europe, not anywhere. Burnout is classified by the WHO as an occupational phenomenon, not a disease, and no antidepressant, ketamine product or psychedelic holds a burnout indication. Medication enters the picture only when a medical condition (most often depression or an anxiety disorder) is diagnosed alongside or instead of burnout.
Does ketamine help with burnout?
There is no solid trial evidence for ketamine as a burnout treatment, and no approval. Ketamine's real evidence is in depression. If a clinic offers ketamine for your burnout, the honest version of that offer is "we believe you may have depression", and that diagnosis should be made explicitly, not implied.
Is burnout just depression by another name?
No, but they overlap heavily and are confused in both directions. Burnout is anchored in the work situation and lifts with recovery and workplace change; depression pervades life beyond work and has formal diagnostic criteria. Severe, persistent symptoms (low mood most of the day, loss of interest across the board, hopelessness) warrant a proper clinical assessment, because if it is depression, a real treatment ladder exists.
What actually has evidence for burnout?
Work-directed change (workload, role, return-to-work planning), genuine recovery, and structured psychological support such as CBT-based and stress-management approaches, ideally combined. It is unglamorous, and it is what the intervention literature supports.
Sources
- WHO: Burn-out an "occupational phenomenon": International Classification of Diseases (ICD-11, QD85): who.int
- EMA: Spravato (esketamine): approved indication is treatment-resistant depression: ema.europa.eu
- PsyAccess: ketamine evidence review: /guides/ketamine-evidence/; psilocybin evidence review: /guides/psilocybin-evidence/
- PsyAccess: depression treatment isn't working: your options: /guides/depression-treatment-not-working/